Overview

A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI).
Phase:
Phase 3
Details
Lead Sponsor:
The Medicines Company
Treatments:
Cangrelor
Clopidogrel
Ticlopidine